Josh Lauring
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Molecular Biology top 5%
- Epigenetics and DNA Methylation
- PI3K/AKT/mTOR signaling in cancer
- Cancer-related gene regulation
- Protein Degradation and Inhibitors
- RNA modifications and cancer
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 8
- Protein Kinase Regulation and GTPase Signaling 6
- CRISPR and Genetic Engineering 5
- Ubiquitin and proteasome pathways 4
- Protein Degradation and Inhibitors 4
-
- Renal cell carcinoma treatment 4
- Co-authors
- Ben Ho Park (17 shared papers)Mark S. Schlissel (3 shared papers)John P. Gustin (10 shared papers)Joseph P. Garay (9 shared papers)Kyung Hee Yi (4 shared papers)Abde M. Abukhdeir (8 shared papers)Hiroyuki Konishi (7 shared papers)Antonio C. Wolff (3 shared papers)
- Journals
- Oncotarget (5 papers)Journal of Clinical Oncology (5 papers)Annals of Oncology (3 papers)Journal of the National Comprehensive Cancer Network (3 papers)Proceedings of the National Academy of Sciences (3 papers)
- Partner nations
- United StatesSpainNetherlands
In The Last Decade
Josh Lauring
42 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 104
- Cancer Research 442
- Molecular Biology 1.4k
- Oncology 455
- Hematology 144
- Immunology 245
Countries citing papers authored by Josh Lauring
This map shows the geographic impact of Josh Lauring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josh Lauring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josh Lauring more than expected).
Fields of papers citing papers by Josh Lauring
This network shows the impact of papers produced by Josh Lauring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josh Lauring. The network helps show where Josh Lauring may publish in the future.
Co-authors
The 25 scholars most cited alongside Josh Lauring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 340 | |
| 2 | 2016 | 297 | |
| 3 | 2007 | 126 | |
| 4 | 2003 | 124 | |
| 5 | 2009 | 121 | |
| 6 | 2013 | 95 | |
| 7 | 2015 | 84 | |
| 8 | 2013 | 78 | |
| 9 | 2007 | 75 | |
| 10 | 2007 | 72 | |
| 11 | 2017 | 58 | |
| 12 | 1999 | 56 | |
| 13 | 2014 | 52 | |
| 14 | 2015 | 49 | |
| 15 | 2022 | 47 | |
| 16 | 2000 | 46 | |
| 17 | 2010 | 45 | |
| 18 | 2012 | 35 | |
| 19 | 2015 | 30 | |
| 20 | 2018 | 30 |
About Josh Lauring
Josh Lauring is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Surgery, having authored 42 papers that have together received 2.1k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (8 papers), Cancer Genomics and Diagnostics (6 papers), Protein Kinase Regulation and GTPase Signaling (6 papers), Bladder and Urothelial Cancer Treatments (5 papers), CRISPR and Genetic Engineering (5 papers), Ubiquitin and proteasome pathways (4 papers), Renal cell carcinoma treatment (4 papers) and Protein Degradation and Inhibitors (4 papers). The work is most often cited by research in Cancer Research (442 citations), Molecular Biology (1.4k citations), Oncology (455 citations), Hematology (144 citations) and Immunology (245 citations). Josh Lauring has collaborated with scholars based in United States, Spain and Netherlands. Frequent co-authors include Ben Ho Park, Mark S. Schlissel, John P. Gustin, Joseph P. Garay, Kyung Hee Yi, Abde M. Abukhdeir, Hiroyuki Konishi, Antonio C. Wolff, Barry M. Zee and Peggie Cheung. Their work appears in journals such as Oncotarget, Journal of Clinical Oncology, Annals of Oncology, Journal of the National Comprehensive Cancer Network and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.